UK funds human trials of potential COVID-19 vaccine from Imperial

UK funds human trials of potential COVID-19 vaccine from Imperial

Scientists at Imperial College London will start the first clinical trials of a potential COVID-19 vaccine this week with more than 45 million pounds ($56.50 million) in backing from the British government and philanthropic donors.

Leave a Reply

Your email address will not be published. Required fields are marked *

ARE YOU READY? GET IT NOW!
Recieve NuPeak Pro’s Free Nootropics Report
Your Information will never be shared with any third party.